A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018.
Autore principale: | Haque, Mushfiqul |
---|---|
Altri autori: | Kabir, Md. Tanvir |
Natura: | Project report |
Lingua: | English |
Pubblicazione: |
BRAC University
2019
|
Soggetti: | |
Accesso online: | http://hdl.handle.net/10361/11070 |
Documenti analoghi
-
Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024) -
Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
di: Alam, Badrul, et al.
Pubblicazione: (2016) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
di: Flora, Sanzida Alam
Pubblicazione: (2024) -
A review on artemisinin based combination therapy for the treatment of Malaria
di: Chowdhury, Amina Ferdous
Pubblicazione: (2020) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)